AbbVie Declares Quarterly Dividend
The board of directors of AbbVie (NYSE: ABBV) has declared a quarterly cash dividend of $1.48 per share, payable on May 15, 2023, to stockholders of record by the close of business on April 14, 2023.
Since its inception in 2013, AbbVie has increased its dividend by over 270% and is recognized as a member of the S&P Dividend Aristocrats Index, which includes companies that have consistently raised dividends for at least 25 consecutive years.
- Declared quarterly cash dividend of $1.48 per share.
- Dividend increase of over 270% since 2013.
- Member of S&P Dividend Aristocrats Index.
- None.
The cash dividend is payable
Since the company's inception in 2013, AbbVie has increased its dividend by more than 270 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and gastroenterology, in addition to products and services across our Allergan Aesthetics portfolio. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-301749164.html
SOURCE AbbVie
FAQ
What is the dividend amount declared by AbbVie for May 2023?
When is the dividend payment date for AbbVie?
What is the record date to receive AbbVie's dividend?
How much has AbbVie increased its dividend since its inception?
Is AbbVie a member of any dividend index?
